Publication:
Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand

dc.contributor.authorIntragumtornchai T.
dc.contributor.authorBunworasate U.
dc.contributor.authorWudhikarn K.
dc.contributor.authorLekhakula A.
dc.contributor.authorJulamanee J.
dc.contributor.authorChansung K.
dc.contributor.authorSirijerachai C.
dc.contributor.authorNorasetthada L.
dc.contributor.authorNawarawong W.
dc.contributor.authorKhuhapinant A.
dc.contributor.authorSiritanaratanakul N.
dc.contributor.authorNumbenjapon T.
dc.contributor.authorPrayongratana K.
dc.contributor.authorChuncharunee S.
dc.contributor.authorNiparuck P.
dc.contributor.authorSuwanban T.
dc.contributor.authorKanitsap N.
dc.contributor.authorWongkhantee S.
dc.contributor.authorPornvipavee R.
dc.contributor.authorWong P.
dc.contributor.authorMakruasi N.
dc.contributor.authorWannakrairot P.
dc.contributor.authorAssanasen T.
dc.contributor.authorSukpanichnant S.
dc.contributor.authorBoonsakan P.
dc.contributor.authorKanoksil W.
dc.contributor.authorYa-in C.
dc.contributor.authorKayasut K.
dc.contributor.authorMitranun W.
dc.contributor.authorWarnnissorn N.
dc.date.accessioned2021-04-05T03:21:38Z
dc.date.available2021-04-05T03:21:38Z
dc.date.issued2018
dc.date.issuedBE2561
dc.description.abstractSystemic reports on the descriptive epidemiology of non-Hodgkin lymphoma (NHL) from Southeast Asia are scarce. A nationwide multi-institutional registry was conducted to compare the histopathology, clinical features, and survival of Thai adult patients with NHL using large registries, especially those from Far East Asia (FEA). Using a web-based registry system, 13 major medical centers from the 4 geographic regions of Thailand prospectively collected, from 2007 to 2014, the diagnostic pathology, according to the World Health Organization classification, 2008, clinical features and survival of 4056 patients who were newly diagnosed with NHL. The median age of the patients was 56 years (range, 16-99 years). The male-to-female ratio was 1.3:1. From the total of 4056 patients, T/NK-cell lymphoma (TNKCL) accounted for 12.6% of cases, and 5.1% had human immunodeficiency virus–associated lymphoma. The four leading histological subtypes were diffuse large B-cell lymphoma, not otherwise specified (58.1%); follicular lymphoma (5.6%); extranodal mucosa-associated lymphoid tissue lymphoma (5.2%); and peripheral T-cell lymphoma, not otherwise specified (4.0%). With a median follow-up duration of 46.1 months, the median overall survival of B-cell NHL was significantly longer than that of patients with TNKCL (76.5 vs 28.8 months, P =.0001). Compared to FEA, the Thai registry had an approximately one-half lower relative frequency of TNKCL; the prevalence of extranodal mucosa-associated lymphoid tissue lymphoma was much lower than in Korea, and the frequency of extranodal TNKCL, nasal type, was strikingly low compared to China. It is concluded that while the median age of Thai patients with NHL was approximately a decade younger than for Caucasians, the long-term survival rates for most histological subtypes were comparable. While the histological distribution generally complied with the characteristic Asian features, some differences from FEA were observed. Copyright © 2017 John Wiley & Sons, Ltd.
dc.format.mimetypeapplication/pdf
dc.identifier.citationHematological Oncology. Vol 36, No.1 (2018), p.28-36
dc.identifier.doi10.1002/hon.2392
dc.identifier.issn2780232
dc.identifier.other2-s2.0-85017382024
dc.identifier.urihttps://swu-dspace2.eval.plus/handle/123456789/3718
dc.rights.holderScopus
dc.subject.otherAnaplastic lymphoma kinase
dc.subject.otherCyclophosphamide
dc.subject.otherDoxorubicin
dc.subject.otherPrednisolone
dc.subject.otherRituximab
dc.subject.otherVincristine
dc.subject.otherAdult
dc.subject.otherAged
dc.subject.otherAnaplastic large cell lymphoma
dc.subject.otherArticle
dc.subject.otherB cell lymphoma
dc.subject.otherCancer chemotherapy
dc.subject.otherCancer survival
dc.subject.otherChina
dc.subject.otherClinical feature
dc.subject.otherCohort analysis
dc.subject.otherComparative study
dc.subject.otherDiffuse large B cell lymphoma
dc.subject.otherFemale
dc.subject.otherFollicular lymphoma
dc.subject.otherFollow up
dc.subject.otherHistology
dc.subject.otherHistopathology
dc.subject.otherHuman
dc.subject.otherHuman immunodeficiency virus infection
dc.subject.otherHuman tissue
dc.subject.otherKorea
dc.subject.otherLong term survival
dc.subject.otherLymphoblastoma
dc.subject.otherMajor clinical study
dc.subject.otherMale
dc.subject.otherMarginal zone lymphoma
dc.subject.otherMiddle aged
dc.subject.otherNK T cell lymphoma
dc.subject.otherNonhodgkin lymphoma
dc.subject.otherOverall survival
dc.subject.otherPeripheral T cell lymphoma
dc.subject.otherPrevalence
dc.subject.otherPriority journal
dc.subject.otherSubcutaneous t cell lymphoma
dc.subject.otherThailand
dc.subject.otherAdolescent
dc.subject.otherMortality
dc.subject.otherNonhodgkin lymphoma
dc.subject.otherPathophysiology
dc.subject.otherSoutheast Asia
dc.subject.otherSurvival analysis
dc.subject.otherThailand
dc.subject.otherVery elderly
dc.subject.otherYoung adult
dc.subject.otherAdolescent
dc.subject.otherAdult
dc.subject.otherAged
dc.subject.otherAged, 80 and over
dc.subject.otherAsia, Southeastern
dc.subject.otherFemale
dc.subject.otherHumans
dc.subject.otherLymphoma, Non-Hodgkin
dc.subject.otherMale
dc.subject.otherMiddle Aged
dc.subject.otherSurvival Analysis
dc.subject.otherThailand
dc.subject.otherYoung Adult
dc.titleNon-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85017382024&doi=10.1002%2fhon.2392&partnerID=40&md5=dbf345c17062800210dad4a14b237d9f

Files